SOLACI-CACI 2021 | SAC-FAC Session

✔️ Watch again the complete SAC-FAC Session in the SOLACI-CACI 2021 Congress.

👨‍🏫 Program:

– SESSION I: Functional Mitral Regurgitation: New Horizons for Transcatheter Therapy

  • 01:06 – Optimal Medical Treatment in Patients with Cardiac Failure and Mitral Regurgitation – Florencia Renedo
  • 12:12 – Ultrasonographic Screening of Patients for Endovascular Therapy – Walter García
  • 25:43 – Mitral Valve Percutaneous Repair. Evidence. An Interventional Cardiologist’s Perspective – Jaime Fonseca

👉🏻 Chairpersons: Session I: Eduardo Perna
👉🏻 Panelists: Agüero, Marcelo – Cursack, Guillermo – Fernández Murga, Arturo – Garófalo, Pablo – Larribau, Miguel – Vigo, Santiago José

SESSION II: Medical Treatment and Revascularization in Patients with Chronic Coronary Syndrome

  • 53:09 – Optimal Medical Treatment – Juan Muntaner
  • 01:04:44 – Non-Invasive Diagnostic Methods – Roxana Campisi
  • 01:16:10 – Endovascular Revascularization – Daniel Berrocal

👉🏻 Chairpersons: Session II: Alejandro Hershson & Alejandro Machaín
👉🏻 Panelists: Comtesse, Daniel – Higa, Claudio – Moreyra, Eduardo – Navarro Estrada, José Luis – Pérez Baliño, Pablo – Tajer, Carlos – Swieszkowski, Sandra


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart failure, and increased mortality, even under optimal...

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

Courtesy of Dr. Juan Manuel Pérez. After post percutaneous coronary intervention (PCI) standard duration dual antiplatelet therapy (DAPT), the optimal long term monotherapy strategy is...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...